• The literature related to pain and postoperative management in Rett syndrome is equivocal; case study evidence indicates possible reduced pain sensitivity and reduced need for analgesia, whereas direct behavioral pain assessment findings indicate evidence for preserved pain expression which would suggest conventional analgesic management is warranted.
Introduction
Rett syndrome is a rare genetic disorder with an estimated incidence of 1 in 10 000. Rett syndrome almost exclusively affects females and is caused by mutations in the methylCpG-binding protein 2 gene (MECP2). The disease is characterized by the progressive loss of previously acquired developmental milestones typically between the age of 6-18 months followed by the development of stereotypical hand movements, severe impairments in language, and gait apraxia. The majority of girls and women with Rett syndrome also have epilepsy, autonomic, and respiratory concerns (e.g., breath holding, increased risk for pneumonia), gastroesophageal reflux, constipation and associated gastrointestinal issues, and scoliosis (1, 2) .
Despite the myriad health conditions experienced by girls with Rett syndrome, some likely to be associated with pain, pain insensitivity remains part of the diagnostic criteria. The initial scientific evidence for pain insensitivity was derived from several case study reports. Early case studies highlighted the lack of response/reactivity in girls with Rett syndrome during accidental injuries (e.g., falls, exposure to fire) (3) . In a more recent large survey study (n = 646), the majority of parents responding to a single item reported reduced pain sensitivity in their daughters (although, some did report increased sensitivity) (4) . This study by Down and colleagues (2010) also provided preliminary evidence that genotype may play a role in pain sensitivity, as a C-terminal, p.R168X or p.R306C mutation was associated with decreased pain sensitivity.
In a subsequent survey study, in which parents were asked more specific questions about their daughter's pain based on items from a validated nonverbal pain scale, the majority reported that their daughters experienced a great deal of chronic pain. Almost a quarter of the sample (24%; out of 44) reported that their daughters experienced pain for more than 7 days in the previous month (5) . The frequency of pain episodes significantly correlated with the number of pain sources and the number of chronic health conditions (5) . In a further investigation examining the relation between parent report (proxy report of pain symptoms) and directly observed pain behaviors (pain signs) during a physical exam-based procedure, Barney et al. (6) found that the majority of parents (89%) reported their daughter had experienced pain in the previous week. The most common etiologies of chronic pain included gastrointestinal, musculoskeletal, and seizure-related pain. On average, the pain reported was intense (rated 6 out of 10) and long in duration (lasting up to 25 h in the previous week). Parents reported a broad array of modalities through which their daughters expressed pain (e.g., facial expressions, vocalization). Pain expression also appeared intact and frequent when coded observationally during a physical exam consistent with behavioral pain expression in other nonverbal populations with severe neurodevelopmental disabilities (6) .
The detailed subjective reports of pain experience and objective coding of pain expression during physical exam in girls with Rett syndrome suggests the issue surrounding pain in Rett syndrome may be a detection issue rather than a sensitivity issue (5, 6) . Severe motor and communicative impairments limit the ability of girls and women with Rett syndrome to communicate their pain experiences in conventional ways (i.e., self-report). Because of this, there is the possibility that pain may be overlooked and undertreated in Rett syndrome. This possibility is further supported by the finding that despite concerns about health, almost half (43%) of parents reported they were unsure how to tell reliably when their daughter was in pain (5) .
Given the general health issues associated with the syndrome and the ambiguity (and difficulty) in detecting pain expression, optimizing medical care in general and pain management in particular remains a challenge.
Painful surgical procedures are likely to occur for girls and women with Rett syndrome. Scoliosis is present in 50% of girls with Rett syndrome frequently leading to spinal fusion, tonsillectomies are performed to treat obstructive sleep apnea, and gastrostomy tube placement is often required to resolve feeding issues (7) (8) (9) . Considering the complexities of pain assessment in girls with Rett syndrome and the diagnostic criteria indicating pain insensitivity, there seems reason to be concerned about how pain is managed in the postoperative period. In a previous study investigating postoperative pain management following spinal fusion surgery for children with and without cognitive impairment, children with cognitive impairments received significantly less total opioids and were less likely to have their pain assessed consistently (10) . Specific to Rett syndrome, there have been case reports documenting reduced postoperative analgesic requirements and increased sensitivity to sedatives in Rett syndrome following surgical intervention (11) (12) (13) . The case studies included behavioral ratings and maternal report and suggested reduced pain (expression). Other case reports document reduced use of sedatives during painful procedures for girls with Rett syndrome based, in part, on prior claims regarding reduced analgesic requirement in the Rett syndrome population (14) . A recent retrospective review of 24 girls with Rett syndrome undergoing 29 surgical procedures did not confirm the case study reports of reduced analgesic requirements following surgery. Although a control group was not included, the type and dosing of opioids delivered did not differ from standard practice for pediatric populations (2) . Additionally, when eight girls with Rett syndrome were compared to large samples of girls with idiopathic scoliosis and girls with neurologic scoliosis, Rumbak et al. (15) found that girls with Rett syndrome actually received significantly more morphine equivalent opioids postoperatively compared to the typically developing girls with idiopathic scoliosis.
The purpose of the current study was to further compare postoperative pain assessment scores and management practices in girls with Rett syndrome and extend the Karmaniolou et al. (2) study by comparing a Rett syndrome sample against age-and gender-matched controls across the same surgical procedure. Because previous studies have shown a discrepancy in pain management based on cognitive impairment associated with developmental delay (10), two comparison groups were included in this study. One comparison group included typically developing adolescent females with adolescent idiopathic scoliosis and the other group included female adolescents with cerebral palsy with severe motor and communicative impairments. The aim of this study was to compare the total opioid doses for girls with compared to girls with AIS (no motor or cognitive impairments) and girls with CP (severe motor and cognitive impairments comparable to Rett syndrome) all of whom underwent spinal fusion surgery.
Methods
Following institutional review board approval, all 12 children with Rett syndrome who had undergone spine fusion surgery at a local tertiary care hospital were identified from the surgical database. A review of medical records was conducted to select two age-, gender-, and procedure-matched control groups, one group with adolescent idiopathic scoliosis and one group with cerebral palsy (CP). Control participants were selected based on having the closest age match (at time of surgery) to each participant with Rett syndrome. If more than one participant was an exact match, then participants were chosen in alphabetical order based on surname. Participants were included in the study if they had had spinal fusion surgery and received a morphine or morphine equivalent (e.g., hydromorphone) nurse-or patientcontrolled analgesia (N/PCA) pump to manage postoperative pain.
A review of the medical records confirmed that all girls with Rett syndrome included in the study had significant motor impairments, were nonverbal, and had their pain assessed using an observational pain scale (rather than verbal self-report). Therefore, girls with CP were included in the study if the medical records also stated that they had severe motor impairments (defined as Gross Motor Function Classification System [GMFCS] levels III-V), and had their pain assessed using a nonverbal observational pain scale. Girls with adolescent idiopathic scoliosis were included in the study if they did not have any comorbid conditions, motor or cognitive impairments, and were assessed for pain using a verbal self-report scale. Surgeries occurred from 1998 to 2012. Four girls with Rett syndrome initially identified received fentanyl N/ PCA pumps and were excluded from the study. Upon further review of their medical records, two girls with CP were determined to communicate verbally and were excluded and replaced with participants who met the inclusion criteria. This resulted in a final sample of eight girls in each group. Documentation of demographic data, surgical procedure, and extent of cognitive and motor impairment were recorded from physician notations. Postoperative medications (opioid N/PCA continuous infusion and bolus doses, adjuvant medications), delivery routes, and pain assessment scores were obtained from the daily nursing logs. All participants received a continuous infusion of morphine (or equivalent) from their N/PCA which typically started out at a rate between 0.50 and 1.0 mgÁh À1 at a concentration of 2 mgÁml
À1
. Bolus doses were available to all participants and typically started at a dose between 0.50 and 1.0 mg. The continuous infusion rate and bolus doses available were decreased over time until the N/PCAs were discontinued. The total opioid doses were calculated by adding the continuous infusion rate per hour plus total bolus doses per hour. Opioids were converted to morphine equivalents using standard equianalgesic conversions (16) .
To determine the extent to which daily/chronic medications might impact the postoperative pain management course, daily medication lists were collected for all participants. After extensive review, the only medication taken preoperatively that would be expected to interact with the postoperative pain medications would be gabapentin. Gabapentin is long-acting and could enhance the effects of opioids (17) and therefore may reduce the amount of opioids required in the postoperative period. Gabapentin was taken by one girl with Rett syndrome and one girl with adolescent idiopathic scoliosis prior to spinal fusion surgery. To determine the impact of gabapentin on the study findings, statistical analyses were conducted a second time with these two participants excluded.
Pain was assessed using either an observational numeric pain scale (Rett syndrome, CP groups) or a verbal self-report numeric pain scale (adolescent idiopathic scoliosis group). The verbal report of pain was measured on a 6-point scale with 0 meaning 'happy, no pain', 1 meaning 'hurts a little', 2 meaning 'hurts', 3 meaning 'hurts even more', 4 meaning 'hurts a whole lot', and 5 meaning 'hurts as much as you can imagine'. The observational pain scale measured pain on a 6-point scale with 0 meaning 'no indicators of pain' were observed, 1 meaning 'few indicators of pain' were observed, 2 meaning 'mild indicators of pain' were observed, 3 meaning 'moderate indicators of pain' were observed, 4 meaning 'severe indicators of pain' were observed, and 5 meaning the 'worst indicators of pain' were observed. Because nurses often recorded pain assessments as a range (e.g., 0-1, 2-3, etc.), pain assessment analyses were conducted using the daily maximum pain score recorded per participant. For example, if the most severe pain reported was written as '2-3' for a participant then the daily maximum pain assessment used for the study purposes would be '3'. Thus, mean pain assessment scores are the sum of the daily maximum pain score divided by the participant's length of stay (up to postoperative day 8).
The time frame for data extraction was purposefully large (1998-2012) in order to have a reasonable sample size of girls with Rett syndrome who had undergone spinal fusion surgery. The only hospital practice change noted during this time span was a reduction in the use of codeine over time. We assessed the impact of the large time frame as well as the use of codeine between groups. Data related to opioids and nonopioid adjuvant medications were analyzed in two different ways. First, the dose data were calculated as mgÁkg À1 of drug administered in the postoperative period divided by the participant's length of stay up to postoperative day 8. Second, the data were calculated as mgÁkg À1 of drug given in the postoperative period divided by number of days on which the drug was administered. This second approach provided information related to the average daily dose of the medications. Data on N/PCA morphine equivalent bolus doses were reported by total number of bolus doses administered overall as well as the number of N/PCA bolus doses given per day while the N/PCA was in place. All comparisons between groups were assessed using one-way analyses of variance (ANOVA). Due to the small sample size and the exploratory rather than confirmatory nature of this study, posthoc analyses were conducted using Fisher's least significant difference. Descriptive data are presented as mean, standard deviation, range (95% confidence interval), and n (%) as appropriate.
Results
Demographic data and the nature of surgical procedures for the three groups are presented in Table 1 . Postoperative complications are noted by group in Table 2 . Patients with adolescent idiopathic scoliosis had significantly heavier weights compared to patients with Rett syndrome (95% CI 9.24 to 27.61; P = 0.001) and CP (95% CI 11.03 to 29.39; P = 0.001; see Table 1 ); however, weight was controlled for by converting medication doses to mgÁkg À1 Áday
À1
. Because of the long sampling time frame, we conducted preliminary analyses to determine the impact of the year of surgery and differences in codeine use (a known practice change over time). We found no difference between groups in the amount of codeine ordered (F(2,21) = 0.83, P = 0.45). The groups did not differ by year the surgery was performed (F(2,21) = 0.52, P = 0.60) and there was no significant correlation between year of surgery and total opioids delivered (r = À0.03, P = 0.90). When grouping year of surgery into two 7-year epochs (1998-2004; 2005-2012) , an independent samples t-test detected no significant difference in total opioids given (t(22) = À0.20, P = 0.67) or on average pain scores in the first 5 postoperative days (t(21) = À0.35, P = 0.73).
There was a significant main effect for number of spinal levels fused F(2,21) = 34.93, P < 0.001. Patients with adolescent idiopathic scoliosis had significantly fewer spinal segments fused compared to girls with Rett syndrome (95% CI À7.40 to À4.10; P < 0.001) and girls with CP (95% CI À7.40 to À4.10; P < 0.001). Girls with Rett syndrome did not differ from girls with CP in the number of spinal segments fused (95% CI À1.65 to 1.65; P = 1.0; see Table 1 ). One girl with Rett syndrome had an anterior/posterior fusion with a transthoracic approach and two girls with CP had anterior/posterior fusions-one with a transthoracic approach and one with a thoracic approach. Segments fused were not double counted for anterior/posterior fusions.
Data related to opioids and nonopioid adjuvant medications were analyzed in terms of mgÁkg À1 divided by length of stay (displayed in Table 3 ) as well as by mgÁkg À1 divided by number of days the drug was administered (average daily dose; displayed in Table 4 ). Because these two approaches yielded nearly identical results, findings are based on analysis for mgÁkg À1 by length of stay. There was a statistically significant main effect for morphine equivalent opioids by length of stay F(2,21) = 6.13, P = 0.008. Posthoc comparisons indicated that girls with Rett syndrome received, on average, significantly less opioids compared to girls with adolescent idiopathic scoliosis (95% CI À0.34 to À0.08; P = 0.001) and girls with CP (95% CI À0.27 to À0.02; P = 0.01). There was no difference in total opioids delivered for girls with CP and girls with adolescent idiopathic scoliosis (95% CI À0.04 to 0.19; P = 0.22; See Table 3 and Figure 1 ). Girls with Rett syndrome received significantly less total opioids compared to girls with adolescent idiopathic scoliosis on postoperative day 1 (95% CI À0.44 to À0.02; P = 0.03), day 2 (95% CI À0.62 to À0.01; P = 0.04), day 3 (95% CI À0.56 to À0.04; P = 0.03), and day 4 (95% CI À0.46 to À0.05; P = 0.02). Opioids by day did not differ significantly in any other group comparisons, with one exception on postoperative day 7 when girls with adolescent idiopathic scoliosis received less opioids compared to girls with CP (95% CI À0.26 to À0.03; P = 0.02).
There was a statistically significant main effect for total number of N/PCA bolus doses of morphine equivalent opioids given in the postoperative period Table 3 ). Additionally, there was evidence for a marginal main effect for N/PCA bolus doses per day of morphine equivalent opioids F(2,21) = 3.20, P = 0.06. Posthoc comparisons again indicated that girls with Rett syndrome, on average, received significantly fewer bolus doses of opioids per day compared to girls with adolescent idiopathic scoliosis (95% CI À28.79 to À2.79; P = 0.02). There were no statistically significant differences between the other group comparisons. Groups did not differ statistically on mean acetaminophen, diazepam, propofol, or midazolam delivered during inpatient postoperative recovery (Table 3) . However, there was a significant main effect for the delivery of PRN hydroxyzine F(2,21) = 5.34, P = 0.01 (see Table 3 ). Posthoc comparisons indicated that, on average, girls with Rett syndrome received significantly less hydroxyzine compared to girls with adolescent idiopathic scoliosis (95% CI À1.24 to À0.24; P = 0.006). Girls with CP also received significantly less hydroxyzine compared to girls with adolescent idiopathic scoliosis (95% CI 0.10 to 1.10; P = 0.02). Girls with Rett syndrome did not differ significantly from girls with CP in the amount of hydroxyzine received (95% CI À0.64 to 0.36; P = 0.57).
There was an overall main effect for maximum daily pain recorded during the postoperative inpatient stay (F(2,20) = 9.42, P = 0.001). Girls with Rett syndrome exhibited significantly fewer observational indicators of pain compared to the self-report pain assessment scores of girls with adolescent idiopathic scoliosis (95% CI À1.67 to À0.54; P = 0.001) but pain scores did not differ significantly compared to the observational pain assessment scores for girls with CP (95% CI À0.81 to 0.31; P = 0.36). Observational pain assessment scores for girls with CP were also significantly lower compared to the self-report pain assessment scores of girls with adolescent idiopathic scoliosis (95% CI À1.40 to À0.31; P = 0.004). Descriptively, however, and of note, was that over time it appeared that that the maximum pain ratings for the Rett syndrome sample increased relative to the other two groups. Mean pain assessment scores for each group are presented in Table 3 and pain scores by group by postoperative day are presented in Figure 2 .
Analyses were repeated with two participants excluded to determine if their daily gabapentin medication impacted the study findings. The betweengroup difference for total opioids administered held (F(2,19) = 6.27, P = 0.008). Posthoc comparisons also remain unchanged. Girls with Rett syndrome received, on average, significantly less opioids compared to girls with adolescent idiopathic scoliosis (95% CI À0.37 to À0.09; P = 0.002) and girls with CP (95% CI À0.27 to À0.007; P = 0.04). There was no difference in total opioids delivered for girls with CP and girls with adolescent idiopathic scoliosis (95% CI À0.04 to 0.22; P = 0.17). The between-group differences for total opioids administered by day trended in the same direction but were greater than the P < 0.05 set significance. This might be expected due to reduction in power with reduced sample size. The between-group difference for total number of bolus doses held (F (2,19) = 3.42, P = 0.05). Posthoc comparisons also remain unchanged. Girls with Rett syndrome received significantly fewer bolus doses compared to girls with adolescent idiopathic scoliosis (95% CI À100.75 to À10.68, P = 0.018). The between-group difference for total hydroxyzine held (F(2,19) = 4.73, P = 0.02).
Posthoc comparisons remained unchanged. Girls with Rett syndrome received significantly less hydroxyzine compared to girls with adolescent idiopathic scoliosis (95% CI À1.34 to À0.22, P = 0.009). The between-group differences for average pain scores held despite exclusion of the two participants taking gabapentin (F(2,19) = 12.02, P < 0.001). Posthoc comparisons remained unchanged. Girls with Rett syndrome exhibited significantly fewer observational indicators of pain compared to the self-report pain assessment scores of girls with adolescent idiopathic scoliosis (95% CI À1.78 to À0.67; P < 0.001) but pain scores did not differ significantly compared to the observational pain assessment scores for girls with CP (95% CI À0.79 to 0.28; P = 0.34). Observational pain assessment scores for girls with CP were also significantly lower compared to the self-report pain assessment scores of girls with adolescent idiopathic scoliosis (95% CI À1.51 to À0.44; P = 0.001).
Discussion
In this study, we found evidence for a Rett syndromespecific difference in postoperative pain management following spinal fusion surgery. Girls with Rett syndrome received significantly fewer total doses of opioids compared to girls with CP who had comparable motor and cognitive impairments as well as compared to typically developing girls with adolescent idiopathic scoliosis. As designed, the study does not shed any light on the possible reasons for the documented difference. As reviewed, there are several possibilities including a belief that girls with Rett syndrome are insensitive to pain (which would be an understandable perspective given the diagnostic criteria for the syndrome includes reduced pain sensitivity), and therefore experience less pain. The daily pain ratings, however, seem to contradict this as the Rett syndrome group's pain was rated in the same range as the two comparison groups. It could be considered that girls with Rett syndrome experience chronic pain preoperatively impacting their expression of acute pain postoperatively. Girls with CP, however, are at risk for all the same chronic pain conditions as girls with Rett syndrome (e.g., gastrointestinal pain, musculoskeletal pain) (18, 19) and all three groups (including girls with adolescent idiopathic scoliosis) may experience chronic pain related to severe scoliosis (20) . Thus, chronic pain is unlikely to account for the differences between groups.
There is also the possibility that the observed differences in postoperative opioid analgesic management were based on the notion that there is a reduced analgesic need in Rett syndrome. This is the argument advanced, in part, in several of the prior case studies (11) (12) (13) (14) . There is preclinical evidence that MeCP2 plays an important role in the development of nociceptive pathways, affecting mu opioid receptor regulation (21) which could theoretically impact the way girls with Rett syndrome respond to opioids. However, it remains unknown whether and how the preclinical models of Rett syndrome relate to the pain phenotype of patients with Rett syndrome.
In their postoperative study of Rett syndrome, Karmaniolou et al. (2) did not detect differences in postoperative pain management of girls with Rett syndrome undergoing scoliosis surgery when comparing the experiences of 24 girls to existing pediatric postoperative guidelines. While this is an encouraging finding, the current sample, although smaller, used matched control groups (developmentally typical and developmentally disabled) on age, gender, and surgical procedure-perhaps increasing the ability to detect differences specific to the surgical procedure and its postoperative analgesic management.
A tangential outcome of this study is the clear discordance between pain assessment scores and severity of surgical procedure. The groups with Rett syndrome and CP had significantly more spinal segments fused compared to the group with adolescent idiopathic scoliosis. Additionally, one girl with Rett syndrome and two girls with CP had anterior/posterior spinal fusions, whereas all girls with adolescent idiopathic scoliosis had posterior-only spinal fusions. Potentially, this means that girls with Rett syndrome and CP had more invasive procedures, on average, compared to girls with adolescent idiopathic scoliosis; yet, the nonverbal pain assessment scores in CP and Rett syndrome, on average, were significantly lower compared to the verbal pain assessment scores of the girls with adolescent idiopathic scoliosis. This finding highlights the difficult nature of assessing pain in nonverbal patient populations.
The data presented here are preliminary and descriptive and are intended only as the first steps toward characterizing postsurgical pain management in Rett syndrome. The data were collected retrospectively from existing medical records which limited our ability to assess additional information. For example, we did not have access to nurses' perceptions of pain management practices and we could not choose the pain assessment scales. The pain assessment scales differed between the nonverbal (CP and Rett syndrome) and verbal groups (adolescent idiopathic scoliosis). This, in part, was the reason for including a second control group (CP) to provide a comparison group that was also assessed using an observational pain scale. All participants across groups had posterior spinal fusions with the exception of three individuals who had anterior/posterior spinal fusions introducing some degree of variability in the surgical approach. Group sample sizes were small which undoubtedly reduced statistical power; however, matching participants on age, gender, and surgical procedure increased the precision needed to detect differences between groups.
Further research is needed to determine whether the MeCP2 mutation underlying the Rett syndrome diagnosis impacts the way opioids are metabolized. Given the nature of Rett syndrome syndrome and its underlying pathophysiology, it is reasonable to speculate whether the mechanisms supporting nociceptive signaling are intact. MeCP2 is a crucial protein for neuronal development; the loss of which leads to profound neuronal dysfunction and abnormal brain development. The available evidence from preclinical investigations suggests reflexive pain circuitry is intact but that highorder discriminatory behavior may be impaired (although there may be motor confounds in the behavioral assays making the interpretation of withdrawal latencies and related metrics difficult to interpret) (22) . Of relevance to nociceptive signaling pathways, MeCP2 expression is localized in the dorsal horn of the spinal cord, specifically in neurons, oligodendrocytes, and astrocytes with evidence of opposite effects depending on inflammatory (upregulation) or neuropathic (downregulation) pain models. As mentioned above, there is also preliminary evidence that MeCP2 may be important for mu opioid receptor regulation, with increased MeCP2 activity resulting in hypermethylation of the genomic mu opioid receptor promoter region and consequent reduced mu opioid receptor protein expression (21) . Taken together, it is plausible that through DNA methylation, MeCP2 plays an important role in the development and function of highly relevant components of nociceptive circuitry. The relation between the preclinical models, however, and the clinical pain phenotype is not well established (it has not, to our knowledge, been explicitly investigated).
Clinicians are reminded that recent work has documented a wide repertoire of pain expression in girls with Rett syndrome (6) . Careful examination of the facial, vocal, and overall motor behavior of girls with Rett syndrome may be required to determine the presence and severity of pain. There are many pain assessment tools available such as the Noncommunicating Children's Pain Checklist -Revised (NCCPC-R) (23) , which are recommended for use in clinical practice for any nonverbal patient group with severe disabilities; of particular note there is a postoperative version (24) . In addition, parents and caregivers should be included in clinical discussions surrounding the pain experience of their daughter. Parents provide valuable information when asked specific questions pertaining to the frequency, duration, and intensity of their daughter's pain. The Pediatric Pain Profile (25) , is a tool to facilitate collecting preoperative pain-related information specific to an individual patient with significant disabilities.
Overall, in an era of increasingly personalized medicine and the continued efforts to optimize postoperative analgesia, nonverbal patients with significant disabilities present a clinical challenge. Rett syndrome appears to be a syndrome for which more work is needed; many individuals with Rett syndrome will develop scoliosis and are therefore future surgical candidates. Improving our ability to detect pain in this patient group and tailor postoperative analgesic management should be a priority among the specialized providers that see patients with Rett syndrome. Clinical and bench science could be aligned around this practice problem by working to further clarify whether the MECP2 mutation's exon location determines any difference in mu opioid receptor expression and whether this translates into meaningful differences in the effects of opioids in patients with Rett syndrome.
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